Stock Price
299.02
Daily Change
-0.86 -0.29%
Monthly
-3.99%
Yearly
4.41%
Q3 Forecast
296.92

Cochlear reported AUD1.17B in Sales Revenues for its fiscal semester ending in December of 2024.




Sales Change Date
Ansell USD 834.4M 49.5M Jun/2024
Avita Medical AUD 18.41M 7.89M Dec/2024
Cochlear AUD 1.17B 34.7M Dec/2024
CSL USD 8.21B 1.47B Dec/2024
Fisher Paykel Healthcare NZD 534.9M 416.3M Mar/2025
Healius AUD 933.9M 485.3M Dec/2024
Integral Diagnostics AUD 238.44M 7.19M Jun/2024
Mayne Pharma AUD 195.04M 5.43M Jun/2025
Mesoblast USD 1.56M 950K Dec/2024
Monash IVF AUD 140.31M 11.05M Dec/2024
Nanosonics AUD 93.6M 48.4M Dec/2024
Polynovo AUD 34.58M 24.94M Jun/2025
Ramsay Health Care AUD 9.29B 700M Dec/2025
Regis Healthcare AUD 619.06M 37.36M Dec/2024
ResMed USD 1.35B 65.9M Jun/2025
Sigma Healthcare AUD 1.88B 198.62M Jul/2024
Sonic Healthcare AUD 4.98B 311M Jun/2025
Telix Pharmaceuticals AUD 309.72M 109.32M Jun/2025